141 related articles for article (PubMed ID: 7768293)
1. The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs.
Seki Y; Suzuki Y; Baskaya MK; Kano T; Saito K; Takayasu M; Shibuya M; Sugita K
Eur J Pharmacol; 1995 Mar; 275(3):259-66. PubMed ID: 7768293
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.
Suzuki A; Kotoyori J; Oiso Y; Kozawa O
Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096
[TBL] [Abstract][Full Text] [Related]
3. Role of PAC(1) receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo.
Lamouche S; Yamaguchi N
Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R510-8. PubMed ID: 11208582
[TBL] [Abstract][Full Text] [Related]
4. VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries.
Dalsgaard T; Hannibal J; Fahrenkrug J; Larsen CR; Ottesen B
Regul Pept; 2003 Feb; 110(3):179-88. PubMed ID: 12573798
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
Absood A; Chen D; Wang ZY; Håkanson R
Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
[TBL] [Abstract][Full Text] [Related]
6. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow.
Uddman R; Goadsby PJ; Jansen I; Edvinsson L
J Cereb Blood Flow Metab; 1993 Mar; 13(2):291-7. PubMed ID: 8436621
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxant effect of PACAP-27 on canine cerebral arteries and rat intracerebral arterioles.
Anzai M; Suzuki Y; Takayasu M; Kajita Y; Mori Y; Seki Y; Saito K; Shibuya M
Eur J Pharmacol; 1995 Oct; 285(2):173-9. PubMed ID: 8566136
[TBL] [Abstract][Full Text] [Related]
8. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
[TBL] [Abstract][Full Text] [Related]
9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide stimulates cardiodilatin/atrial natriuretic peptide (CDD/ANP-(99-126) secretion from cultured neonatal rat myocardiocytes.
Bäsler I; Kuhn M; Müller W; Forssmann WG
Eur J Pharmacol; 1995 Nov; 291(3):335-42. PubMed ID: 8719418
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
12. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
13. Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivo.
Gaspo R; Lamarche L; de Champlain J; Yamaguchi N
Am J Physiol; 1997 May; 272(5 Pt 2):R1606-12. PubMed ID: 9176354
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase activating polypeptide (PACAP) redistributes the blood within the pancreas of anesthetized rats.
Carlsson PO; Ostenson CG; Efendic S; Langel U; Jansson L
Regul Pept; 1996 Jul; 63(2-3):123-8. PubMed ID: 8837220
[TBL] [Abstract][Full Text] [Related]
15. PACAP and VIP differentially preserve neurovascular reactivity after global cerebral ischemia in newborn pigs.
Lenti L; Zimmermann A; Kis D; Oláh O; Tóth GK; Hegyi O; Busija DW; Bari F; Domoki F
Brain Res; 2009 Aug; 1283():50-7. PubMed ID: 19538945
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide inhibits the cyclooxygenase pathway of rat cerebral microvessels.
Kis B; Gáspár T; Mezei Z; Gecse A; Telegdy G
Acta Physiol Scand; 1999 Sep; 167(1):43-7. PubMed ID: 10519976
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells.
Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK
J Endocrinol; 1996 May; 149(2):287-95. PubMed ID: 8708540
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
19. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
Ekblad E; Sundler F
Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
